You can purchase shares of Kala Bio (NASDAQ:KALA) through any online brokerage.

View our list of the best stock brokerages

Other companies in Kala Bio’s space includes: Macrogenics Inc (NASDAQ:MGNX), Galectin Therapeutics Inc (NASDAQ:GALT), Humacyte Inc (NASDAQ:HUMA), Atrium Therapeutics Inc (NASDAQ:RNA) and Connect Biopharma Holdings Ltd (NASDAQ:CNTB).

Kala Bio has a consensus price target of $26.00.

The stock price for Kala Bio (NASDAQ: KALA) is $0.2077 last updated March 26, 2026 at 3:27 PM EDT.

There are no upcoming dividends for Kala Bio.

Kala Bio does not have any upcoming earnings scheduled.

There is no upcoming split for Kala Bio.

Kala Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.